INDUSTRY CITY AND SUNSET PARK — Brooklyn-based biotechnology company Cresilon Inc. uncovered a hemostatic gel technology that will make traumatic brain injuries (TBI) significantly less devastating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback